Brief: Scynexis Q1 EPS USD 0.01
08/05/2024 21:30
May 08 (Reuters) - Scynexis Q1 net income USD 411 thousand. * Q1 pretax profit USD 942 thousand * Q1 operating expenses USD 10.881 million * Q1 product revenue USD 1.373 million * Q1 basic EPS USD 0.01
Recent news on Scynexis
See all newsBrief: Scynexis Announces Phase 1 Study Results For Scy-770, A Novel, Highly Selective, Oral Direct Ampk Activator For The Treatment Of Autosomal Dominant Polycystic Kidney Disease
Brief: Scynexis Announces Appointment Of Sanjay Subramanian As Chief Financial Officer
Scynexis Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Scynexis Q2 swings to profit on warrant adjustment; advances drug studies
Scynexis Inc Expected To Post A Loss Of 51 Cents A Share: Earnings Preview